CSL - Pre Tax Profit

Stock Price
146.76
Daily Change
0.74 0.51%
Monthly
-18.55%
Yearly
-43.68%
Q1 Forecast
150.05

CSL reported $1.4B in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Arca Biopharma USD -21M 4.78M Mar/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -2.85M 99K Mar/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
CSL USD 1.4B 1.14B Jun/2025
Curis USD -13.99M 7.38M Jun/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Immunic USD -21.38M 8.2M Jun/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024